Olympus Corporation (OLYMY)

Market Cap	14.10B -15.6%
Revenue (ttm)	6.61B +0.4%
Net Income	662.64M +30.3%
EPS	0.59 +35.7%
Shares Out	n/a
PE Ratio	21.28
Forward PE	n/a
Dividend	0.19 (1.57%)
Ex-Dividend Date	Mar 30, 2026

Volume	69,947
Average Volume	84,454
Open	12.84
Previous Close	12.74
Day's Range	12.81 - 12.88
52-Week Range	11.09 - 14.93
Beta	0.26
RSI	59.67
Earnings Date	Feb 13, 2026

About Olympus

Olympus Corporation, together with its subsidiaries, manufactures and sells medical equipment in Japan, America, the Middle East, Asia, and Oceania. It operates through Endoscopic Solutions Business, Therapeutic Solutions Business, and Other segments. The company offers gastrointestinal endoscopy system products comprising video endoscopy and ultrasound systems; GI endotherapy products consisting of CRC devices and HPB devices/hemostasis products; endoscopic solutions ecosystem products, including intelligent ecosystem operating software platfo...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1919
• Employees: 29,297
• Stock Exchange: OTCMKTS
• Ticker Symbol: OLYMY

Financial Performance

In fiscal year 2025, Olympus's revenue was 997.33 billion, an increase of 6.53% compared to the previous year's 936.21 billion. Earnings were 117.86 billion, a decrease of -51.41%.

Financial numbers in JPY